German biotech CureVac has signed a supply agreement with the European Commission to provide an initial 225 million doses of its mRNA-based Covid-19 vaccine, with an...
UK specialty chemical company Croda International has agreed to supply Pfizer with novel excipients used to make the drugmaker’s Covid-19 vaccine candidate. The contract...
South African chemical group Sasol has started up the seventh and last plant at its glitch-plagued Lake Charles Chemicals Project (LCCP) in Lake Charles, Louisiana, USA...
Results from the Phase 3 trial of US biotech Moderna’s mRNA-1273 Covid-19 vaccine candidate unveiled on Nov. 15 showed it to be 94.5% effective against the novel...
US drugmaker Pfizer and its German development partner BioNTech have reached a final agreement with the European Commission to supply 200 million doses of their mRNA...
Ta’ziz, a joint venture between Abu Dhabi National Oil Company (ADNOC) and compatriot holding company ADQ, will invest more than $5 billion in seven chemical anchor...
Swiss CDMO Lonza has inaugurated the first of two planned state-of-the-art, highly-potent API (HPAPI) suites for antibody-drug conjugate (ADC) drug-linker (payload)...
Phase 3 clinical trials with the mRNA vaccine candidate BNT162b2 being developed by US pharma giant Pfizer and German biotech partner BioNTech have shown it to be more...
Following completion of a comprehensive feasibility study, tentative plans for a major petrochemical complex in India have been shelved for now, due to what the...
